Literature DB >> 11224543

Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs.

M King1, W Su, A Chang, A Zuckerman, G W Pasternak.   

Abstract

Many peptides and transmitters found within the brain also have peripheral sites of action. We now demonstrate that the brain releases functionally active neurotransmitters/neuromodulators directly from the brain into the blood through a saturable P-glycoprotein (Pgp) transport system. Downregulating Pgp1 expression with antisense reduced the brain-to-blood transport of morphine, beta-endorphin and other opioids. Lowering Pgp expression significantly enhanced systemic morphine analgesia and prevented tolerance, but diminished the analgesic activity of centrally administered morphine, implying that supraspinal analgesia resulted from a combination of central and peripheral mechanisms activated by morphine transported from the brain to the blood. Similarly, mice with a disruption of the Mdr1a gene were more sensitive to systemic morphine and less sensitive to morphine given centrally. This ability of the Pgp transport system to pump functionally active compounds from the brain to periphery defines a potentially important mechanism for the central nervous system to modulate peripheral systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11224543     DOI: 10.1038/85115

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  46 in total

1.  Endomorphins exit the brain by a saturable efflux system at the basolateral surface of cerebral endothelial cells.

Authors:  Aniko Somogyvari-Vigh; Abba J Kastin; Jie Liao; James E Zadina; Weihong Pan
Journal:  Exp Brain Res       Date:  2004-05       Impact factor: 1.972

Review 2.  Development of neuropeptide drugs that cross the blood-brain barrier.

Authors:  Richard D Egleton; Thomas P Davis
Journal:  NeuroRx       Date:  2005-01

Review 3.  Transport systems for opioid peptides in mammalian tissues.

Authors:  Vadivel Ganapathy; Seiji Miyauchi
Journal:  AAPS J       Date:  2005-12-29       Impact factor: 4.009

4.  When it comes to opiates, just say NO.

Authors:  Gavril W Pasternak
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

5.  Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.

Authors:  Emily O Dumas; Gary M Pollack
Journal:  AAPS J       Date:  2008-11-07       Impact factor: 4.009

Review 6.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 7.  Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  NeuroRx       Date:  2005-01

Review 8.  Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.

Authors:  Robert Gharavi; William Hedrich; Hongbing Wang; Hazem E Hassan
Journal:  Pharm Res       Date:  2015-05-14       Impact factor: 4.200

9.  Stabilization of morphine tolerance with long-term dosing: association with selective upregulation of mu-opioid receptor splice variant mRNAs.

Authors:  Jin Xu; Andrew J Faskowitz; Grace C Rossi; Mingming Xu; Zhigang Lu; Ying-Xian Pan; Gavril W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

10.  Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice.

Authors:  Yuan Han; Xue-Song Song; Wen-Tao Liu; Mark Henkemeyer; Xue-Jun Song
Journal:  Mol Pain       Date:  2008-11-21       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.